Yesterday Onduo issued a press release which stated;
“Today, Onduo announced its first peer-reviewed publication of clinical outcomes in JDST1. The company published real-world evidence demonstrating significant clinical benefit for people living with type 2 diabetes who participated in its behavior-change program and accessed its virtual diabetes clinic. The article presents data on 740 Onduo participants located in 21 states in the U.S., with 30% living in rural communities. Most notably, the results show that 92% of Onduo participants with the highest initial HbA1c improved their glycemic control, with an average decrease in HbA1c of 2 . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.